Use of solid-phase microextraction coupled to gas chromatography-mass spectrometry for determination of urinary volatile organic compounds in autistic children compared with healthy controls

Analytical and Bioanalytical Chemistry

Volumn 406, Issue 19, 2014, Pages 4649-4662

  Cozzolino, Rosaria ^a   De Magistris, Laura ^b   Saggese, Paola ^a   Stocchero, Matteo ^c   Martignetti, Antonella ^a   Di Stasio, Michele ^a   Malorni, Antonio ^b   Marotta, Rosa ^d   Boscaino, Floriana ^a   Malorni, Livia ^b  

^a National Council Research   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c S IN Soluzioni Informatiche   (Italy)

^d UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

Author keywords

Autism; Orthogonal projections to latent structures discriminant analysis; Solid phase microextraction; Urine samples; Volatile organic compounds

Indexed keywords

ALKALINITY; DISCRIMINANT ANALYSIS; DISEASES; METABOLISM; VOLATILE ORGANIC COMPOUNDS;

AUTISM; AUTISM SPECTRUM DISORDERS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; LATENT STRUCTURES; MULTIVARIATE STATISTICS; PHYSICOCHEMICAL PROPERTY; SOLID-PHASE MICROEXTRACTION; URINE SAMPLE;

GAS CHROMATOGRAPHY;

BIOLOGICAL MARKER; VOLATILE ORGANIC COMPOUND;

AREA UNDER THE CURVE; AUTISM; CHILD; FEMALE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLOMICS; PRESCHOOL CHILD; PRINCIPAL COMPONENT ANALYSIS; PROCEDURES; SOLID PHASE MICROEXTRACTION; URINE;

AREA UNDER CURVE; AUTISTIC DISORDER; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METABOLOMICS; PRINCIPAL COMPONENT ANALYSIS; SOLID PHASE MICROEXTRACTION; VOLATILE ORGANIC COMPOUNDS;

EID: 84904513452     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-014-7855-z     Document Type: Article

References (63)

1. Angley M, Young R, Ellis D, Chan W, McKinnon R (2007) Children and autism-part 1-recognition and pharmacological management. Aust Fam Physician 36:741-744
2. Johnson CP, Myers SM (2007) Identification and evaluation of children with autism spectrum disorders. Pediatrics 120:1183-1215
3. Herb B (2012) Autism. Nature 491:S1-S48
4. Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK (2010) Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls. J Proteome Res 9:2996-3004
5. London EA, Etzel RA (2000) The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect 108:401-404
6. Barnea-Goraly N, Kwon H, Menon V, Eliez S, Lotspeich L, Reiss AL (2004) White matter structure in autism: preliminary evidence from diffusion tensor imaging. Biol Psychol 55:323-326
7. Kałuzna-Czaplińska J, Blaszczyk S (2012) The level of arabinitol in autistic children after probiotic therapy. Nutrition 28:124-126
8. Ming X, Stein TP, Barnes V, Rhodes N, Guo L (2012) Metabolic perturbance in autism spectrum disorders: a metabolomics study. J Proteome Res 11:5856-5862
9. Perry TL, Hansen S, Christie RG (1978) Amino compounds and organic acids in CSF, plasma, and urine of autistic children. Biol Psychiatry 13:575-586
10. Winsberg BG, Sverd J, Castells S, Hurwic M, Perel JM (1980) Estimation of monoamine and cyclic-AMP turnover and amino acid concentrations of spinal fluid in autistic children. Neuropediatrics 11:250-255
11. Rolf LH, Haarmann FY, Grotemeyer KH, Kehrer H (1993) Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand 87:312-316
12. Tirouvanziam R, Obukhanych TV, Laval J, Aronov PA, Libove R, Banerjee AG, Parker KJ, O'Hara R, Herzenberg LA, Herzenberg LA, Hardan AY (2012) Distinct plasma profile of polar neutral amino acids, leucine, and glutamate in children with autism spectrum disorders. J Autism Dev Disord 42:827-836
13. Ratajczak HV (2011) Theoretical aspects of autism: biomarkers-a review. J Immunot 8:80-94
14. Rossignol DA, Frye RE (2012) Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis. Mol Psychiatry 17:290-314
15. Laszlo A, Horvath E, Eck E, Fekete M (1994) Serum serotonin, lactate and pyruvate levels in infantile autistic children. Clin Chim Acta 229:205-207
16. Bradstreet JJ, Smith S, Baral M, Rossignol DA (2010) Biomarker-guided interventions of clinically relevant conditions associated with autism spectrum disorders and attention deficit hyperactivity disorder. Altern Med Rev 15:15-32
17. James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:1611-1617
18. Adams JB, Audhya T, McDonough-Means S, Rubin RA, Quig D, Geis E, Gehn E, Loresto M, Mitchell J, Atwood S, Barnhouse S, Lee W (2011) Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr Metab 8:34-65
19. Gu F, Chauhan V, Kaur K, Brown WT, LaFauci G, Wegiel J, Chauhan A (2013) Alterations in mitochondrial DNA copy number and the activities of electron transport chain complexes and pyruvate dehydrogenase in the frontal cortex from subjects with autism. Transl Psychiatr 3:1-8
20. Parracho HMRT, Bingham MO, Gibson GR, McCartney AL (2005) Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 54:987-991
21. de Magistris L, Familiari V, Pascotto A, Sapone A, Frolli A, Iardino P, Carteni M, De Rosa M, Francavilla R, Riegler G, Militerni R, Bravaccio C (2010) Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 51:418-424
22. Williams BL, Hornig M, Parekh T, Lipkin WI (2012) Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. mBio 3:1-3
23. De Angelis M, Piccolo M, Vannini L, Siragusa S, De Giacomo A, Serrazzanetti DI, Cristofori F, Guerzoni ME, Gobbetti M, Francavilla R (2013) Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS ONE 8:e76993
24. Wang L, Angley MT, Gerber JP, Sorich MJ (2011) A review of candidate urinary biomarkers for autism spectrum disorder. Biomarkers 16:537-552
25. Żurawicz E, Kałużna-Czaplińska J, Rynkowski J (2013) Chromatographic methods in the study of autism. Biomed Chromatogr 27:1273-1279
26. Madsen R, Lundstedt T, Trygg J (2010) Chemometrics in metabolomics-a review in human disease diagnosis. Anal Chim Acta 659:23-33
27. Mills GA, Walker V (2001) Headspace solid-phase microextraction profiling of volatile compounds in urine: application to metabolic investigations. J Chromatogr B Biomed Sci Appl 753:259-268
28. Zlatkis A, Brazell RS, Poole CF (1981) The role of organic volatile profiles in clinical diagnosis. Clin Chem 27:789-797
29. Wahl HG, Hoffmann A, Luft D, Liebich HM (1999) Analysis of volatile organic compounds in human urine by headspace gas chromatography-mass spectrometry with a multipurpose sampler. J Chromatogr A 847:117-125
30. Shirasu M, Touhara K (2011) The scent of disease: volatile organic compounds of the human body related to disease and disorder. J Biochem 150:257-266
31. Lechner M, Rieder J (2007) Mass spectrometric profiling of low-molecular-weight volatile compounds-diagnostic potential and latest applications. Curr Med Chem 14:987-995
32. Banday KM, Pasikanti KK, Chan EC, Singla R, Rao KV, Chauhan VS, Nanda RK (2011) Use of urine volatile organic compounds to discriminate tuberculosis patients from healthy subjects. Anal Chem 83:5526-5534
33. Silva CL, Passos M, Câmara JS (2011) Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry. Br J Cancer 105:1894-1904
34. Silva CL, Passos M, Câmara JS (2012) Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers-a powerful strategy for breast cancer diagnosis. Talanta 89:360-368
35. Pawliszyn J (2009) Handbook of Solid Phase Microextraction. Chemical Industry Press, Beijing
36. Nicholson JK, Lindon JC (2008) Systems biology: metabonomics. Nature 455:1054-1056
37. Jackson JE (1991) A users guide to principal components. John Wiley, New York
38. Barker M, Rayens W (2007) Partial least squares for discrimination. J Chemometr 17:166-173
39. Trygg J, Wold S (2002) Orthogonal projections to latent structures (O-PLS). J Chemom 16:119-128
40. Trygg J, Holmes E, Lundstedt T (2007) Chemometrics in metabonomics. J Proteome Res 6:469-479
41. Broadhurst DI, Kell DB (2006) Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2:171-196
42. Westerhuis JA, Hoefsloot HCJ, Smit S, Vis DJ, Smilde AK, van Velzen EJJ, van Duijnhoven JPM, van Dorsten FA (2008) Assessment of PLSDA cross validation. Metabolomics 4:81-89
43. Fawcett T (2006) An introduction to ROC analysis. Pattern Recogn Lett 27:861-874
44. Kataokaa H, Lordb HL, Pawliszynb J (2000) Applications of solid-phase microextraction in food analysis. J Chromatogr A 880:35-62
45. Zhang Z, Pawliszyn J (1993) Headspace solid-phase microextraction. Anal Chem 65:1843-1852
46. Deng C, Zhang X, Li N (2004) Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry. J Chromatogr B 808:269-277
47. Mochalski P, Wzorek B, Sliwka I, Amann A (2009) Improved pre-concentration and detection methods for volatile sulphur breath constituents. J. Chromatogr B 877:1856-1866
48. Lindon JC, Nicholson JK, Holmes E, Keun HC, Craig A, Pearce JTM, Bruce SJ, Hardy N, Sansone SA, Antti H, Jonsson P, Daykin C, Navarange M, Beger RD, Verheij ER, Amberg A, Baunsgaard D, Cantor GH, Lehman-McKeeman L, Earll M, Wold S, Johansson E, Haselden JN, Kramer K, Thomas C, Lindberg J, Schuppe-Koistinen I, Wilson ID, Reily MD, Robertson DG, Senn H, Krotzky A, Kochhar S, Powell J, van der Ouderaa F, Plumb R, Schaefer H, Spraul M (2005) worki SMRS (is this right), Summary recommendations for standardization and reporting of metabolic analyses. Nat Biotechnol 23:833-838
49. Goodacre R, Broadhurst D, Smilde AK, Kristal BS, Baker JD, Beger R, Bessant C, Connor S, Calmani G, Craig A, Ebbels T, Kell DB, Manetti C, Newton J, Paternostro G, Somorjai R, Sjostrom M, Trygg J, Wulfert F (2007) Proposed minimum reporting standards for data analysis in metabolomics. Metabolomics 3:231-241
50. Worley B, Powers R (2013) Multivariate analysis in metabolomics. Curr Metabolomics 1:92-107
51. Dieterle F, Ross A, Schlotterbeck G, Senn H (2006) Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. application in 1H NMR metabonomics. Anal Chem 78:4281-4290
52. Veselkov KA, Vingara LK, Masson P, Robinette SL, Want E, Li JV, Barton RH, Boursier-Neyret C, Walther B, Ebbels TM, Pelczer I, Holmes E, Lindon JC, Nicholson JK (2011) Optimized preprocessing of ultra performance liquid chromatography/mass spectrometry urinary metabolic profiles for improved information recovery. Anal Chem 83:5864-5872
53. Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikström C, Wold S (2006) Multi- and megavariate data analysis. Basic principles and applications. Appendix, IIth edn. Umetrics AB, Sweden, Umeå
54. Wiklund S, Johansson E, Sjöstroöm L, Mellerowicz EJ, Edlund U, Shockcor JP, Gottfries J, Moritz T, Trygg J (2008) Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal Chem 80:115-122
55. Smit BA, Engels WJM, Smit G (2009) Branched chain aldehydes: production and breakdown pathways and relevance for flavour in foods. Appl Microbiol Biotechnol 81:987-999
56. Chauhan A, Chauhan V, Brown WT, Cohen I (2004) Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin-the antioxidant proteins. Life Sci 75:2539-2549
57. Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT (1999) Gastrointestinal abnormalities in children with autistic disorder. J Pediatr 135:559-563
58. Kushak RI, Lauwers GY, Winter HS, Buie TM (2011) Intestinal disaccharidase activity in patients with autism: effect of age, gender, and intestinal inflammation. Autism 15:285-294
59. Maga JA (1992) Wazines update. Food Rev Znt 8:479-558
60. Lancker FV, Adams A, De Kimpe N (2010) Formation of pyrazines in Maillard model system of lysine-containing dipeptides". J Agric Food Chem 58:2470-2478
61. Nicolotti L, Cordero C, Bicchi C, Rubiolo P, Sgorbini B, Liberto E (2013) Volatile profiling of high quality hazelnuts (Corylus avellana L.): chemical indices of roastin. Food Chem 138:1723-1733
62. Kim YH (2013) An accurate and reliable analysis of trimethylamine using thermal desorption and gas chromatography-time of flight mass spectrometry. Anal Chim Acta 780:46-54
63. Mitchell SC, Zhang AQ, Smith RL (2002) Chemical and biological liberation of trimethylamine from food. J Food Comp Anal 15:277-282